Advertisement
Neurologic manifestations are common among hospitalized patients with COVID-19

Neurologic Effects Seen in a Third of Hospitalized COVID-19 Patients

0
Manifestations include acute cerebrovascular diseases, impaired consciousness, skeletal muscle injury
Ambient temperature and ultraviolet radiation are not associated with the cumulative incidence rate or basic reproduction number of coronavirus disease 2019

Temperature, UV Radiation Not Linked to Incidence of COVID-19

0
Spread ability of COVID-19 not expected to change with increasing temperature, increasing UV exposure
A report issued by the U.S. Department of Health and Human Services Office of Inspector General provides a national snapshot of hospital experiences in response to the coronavirus disease 2019.

HHS Report Looks at Hospital Experiences With COVID-19

0
Most significant challenges relate to testing and caring for COVID-19 patients, keeping staff safe
One dose of convalescent plasma therapy is well tolerated and can potentially improve clinical symptoms in severe cases with coronavirus disease 2019

Convalescent Plasma Treatment Promising in Severe COVID-19

0
One dose of CP with neutralizing antibodies can reduce viral load, tends to improve clinical symptoms
Stage at diagnosis

Racial Differences Seen for Cancer Diagnosis, Treatment, Survival

0
White, black, and Hispanic patients have worse odds of cancer-specific and overall survival versus Asian patients
Researchers have identified the most common clinical characteristics among 109 patients out of 1

Older Adults, Men, Preexisting Conditions Tied to COVID-19 Death

0
Patients admitted to ICU lived longer, but bed shortages in Wuhan prevented admission for all who needed it
Another clinical trial of an experimental vaccine for the novel coronavirus 2019 has been launched by U.S. researchers.

Another COVID-19 Vaccine Trial Begins in the United States

0
Experimental vaccine is given using a skin-deep shot instead of the typical deeper jab
A clinical trial to assess the antimalarial drug hydroxychloroquine as a treatment for adults with the novel coronavirus is now underway

NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19

0
Enrollees include more than 500 adults hospitalized or expected to be hospitalized with COVID-19
The novel coronavirus has been circulating in New York City for longer than previously believed and most cases can be traced back to Europe

COVID-19 Came to New York City From Europe, Not Asia

0
Specific genetic codes in most New York City viral samples indicate they originated in Europe
Doctors at the University of Alabama at Birmingham are enrolling patients in an international clinical trial to find out if inhaled nitric oxide benefits those with novel coronavirus who have severely damaged lungs.

Clinical Trial Underway to Test Nitric Oxide in COVID-19 Patients

0
Nitric oxide can improve blood flow in areas of the lungs still receiving air, may have antiviral properties